Bayer China Inks Partnership With VeChain, Co-Develops CSecure Clinical Trials Platform

News
Thu, 05/28/2020 - 15:07
article image
Vladislav Sopov
VeChain, a Singapore-based development team, is a leader in real-world blockchain adoption. Now it is helping pharma giant Bayer advance their clinical trials
Bayer China Inks Partnership With VeChain, Co-Develops CSecure Clinical Trials Platform
Cover image via stock.adobe.com
Read U.TODAY on
Google News
Contents

VeChain Foundation has announced that Bayer China is working with their team on the development of a blockchain-based framework that will advance the traceability of clinical drug trials.

VeChain, Bayer's 'partner-for-life'

According to the project team, the VeChain platform was chosen by the pharmaceutical production mogul within the framework of the 2019 Bayer China Grants For Apps Partnerships Program.

Through this program, Bayer chooses the most advanced product teams to tackle significant business tasks. Digitized clinical trial traceability was among those 'hard-to-solve' problems for Bayer in 2019. Pharma giant needed trustless all-in-one solution for unmatched level of transaperency.

The applicants worked directly with specific departments of Bayer China for 45 days to design a comprehensive solution for the business task. The selection process included three stages. Numerous teams over the globe were assigned for this program.

VeChain managed to create a feasible solution and present it to Bayer China's top management. As a result, the VeChain team unveiled CSecure, a clinical trial traceability platform.

BaaS for Big Pharma

The platform is powered by Toolchain, the native modular Blockchain-as-a-Service (BaaS) solution by VeChain. It enables easy and fast deployment of blockchain-based instruments to solve real-world tasks.

The CSecure platform protects the integrity of data at every stage of the supply chain: from producers to end customers. The decentralized nature of data storage makes any type of corruption and data abuse impossible. In terms of business process, the introduction of this instrument significantly reduces the costs of risk management on all stages of product life cycle.

The program works on top of the VeChainThor blockchain. Each medical product receives a unique QR-code, also registered as a VeChainID (VID). Data collected through clinical trials backed by CSecure are used for new drugs, vaccines, dietary supplements and healthcare gadgets.

As previously reported, VeChain was chosen as a partner for the 'The Way of The Tiger' blockchain-based gamebook by Microsoft.

article image
About the author

Blockchain Analyst & Writer with scientific background. 5+ years in IT-analytics, 2+ years in blockchain.

Worked in independent analysis (Crypto Briefing) as well as in start-ups (Swap.online, Monoreto, Attic Lab etc.)

2,500,000 Ethers Locked in Ethereum 2.0 Deposit Contract as ETH Rejected From $1,250

News
Fri, 01/15/2021 - 18:02
article image
Vladislav Sopov
Ethereum 2.0 enthusiasts deposited whopping sum in its contract launched six weeks ago
2,500,000 Ethers Locked in Ethereum 2.0 Deposit Contract as ETH Rejected From $1,250
Cover image via stock.adobe.com
Read U.TODAY on
Google News
Contents

While crypto markets are trying to get out of the most painful correction in this bullish cycle, the Ethereum 2.0 deposit contract accomplishes another crucial milestone.

ETH2 deposit contract surpasses $3,000,000,000 level

According to leading Ethereum network observer Etherscan, the Ethereum 2.0 deposit contract (0x00000000219ab540356cBB839Cbe05303d7705Fa) allocated more than 2.5 million Ethers. New 32-ETH stakes are transferred to it every minute.

ETH2 deposit contract breaks above $3B
Image by Etherscan

As the correction of the Ethereum (ETH) price ended, ETH is changing hands at $1,225: the $1,250 level was too difficult for bulls to conquer. Meanwhile, even at press time, it is worth almost $40,000 to join the club of Ethereum 2.0 stakers.

Therefore, the USD-denominated value of assets locked in the contract surpassed $3 billion for the first time ever and keeps surging.

It should be noted that Ethereum 2.0’s deposit contract went live on Dec. 1, 2020, heralding the start of ETH2 Pase Zero or Beacon Chain, the inaugural stage of Ethereum 2.0.

Ethereum 2.0 “entry tickets” become really expensive

At press time, more than 52,267 addresses transferred money to the deposit contract.

Ironically, Black Thursday in Crypto (March 13, 2020) was the most convenient time to join Ethereum 2.0 staking with Ether at $95. Today, Ethereum (ETH) enthusiasts should pay 13 times more to have a minimum amount of Ethers required for staking.

Ethereum 2.0 is a proof of stake (PoS) iteration of the Ethereum (ETH) protocol. It replaces mining by staking and splits the whole Ethereum (ETH) network into several interconnected sub-chains (shards).

According to Staking Rewards analytical dashboard, annualized rewards for ETH staking are estimated between 10.4 and 10.6 percent.

article image
About the author

Blockchain Analyst & Writer with scientific background. 5+ years in IT-analytics, 2+ years in blockchain.

Worked in independent analysis (Crypto Briefing) as well as in start-ups (Swap.online, Monoreto, Attic Lab etc.)